22 November 2017
News and Views
Links and Services
Intervention for major depressive disorder in patients with cancer is feasible, acceptable, and potentially cost effective, find researchers in the latest issue of the Lancet.
Major depressive disorder can severely impair the quality of life of patients with cancer.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors